HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief: Elizabeth Arden, Ronkin Part Ways; Lauder Execs Advance; More

This article was originally published in The Rose Sheet

Executive Summary

LUXE Brands and Fekkai Brands, which the former created through a joint venture earlier this year to acquire the Frederic Fekkai brand from P&G, will be led by Joel Ronkin, who has left Elizabeth Arden after 16 years of service. More people news.

You may also be interested in...



In Brief: Contamination Recall; ‘Made In America’ Questioned; More

Contract manufacturer Sensible Organics recalls Nourish Organic facial skin-care items due to potential contamination; Revlon's "Almay Simply American" marketing comes under fire for alleged deception. More news in brief.

QUOTED. 21 April 2021. Nicholas McQuaid.

A patient recruiter got 10 years in prison for his role in a scheme to convince seniors to get unneeded and expensive genetic tests. Nicholas McQuaid, acting assistant attorney general of the Justice Department’s Criminal Division, discussed the case.

Is The US FDA At A Tipping Point?

Wall Street is worried that a cluster of recent negative regulatory events means tougher reviews going forward. That concern is probably overdone, but a year into the COVID pandemic is a good time to take stock of how FDA is doing.

Related Companies

UsernamePublicRestriction

Register

RS019749

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel